Clinical Trial Update: A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED) [Phase 1]

View source ↗

Summary

A Phase 1 trial completed evaluating safety and antibody response of V212 in healthy adults for herpes zoster.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• V212

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 1 | Status: COMPLETED | Results posted: 2019-11-08